EdgarLookup

Celldex Therapeutics, Inc. — All Filings

1,002 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 4 4/A 424B1 424B2 424B3 424B5 425 5 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFR14A DEL AM EFFECT NT 10-K NT 10-Q POS AM PRE 14A REGDEX S-3 S-3/A S-3ASR S-3MEF S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
424B5 424B5 0001104659-21-091181 Jul 12, 2021
8-K FORM 8-K 0001104659-21-088220 Jul 1, 2021
4 FORM 4 - 0001179110-21-006908 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006909 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006910 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006911 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006907 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006905 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006912 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006887 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006888 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006904 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006889 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006890 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006892 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006903 Jun 21, 2021 Jun 17, 2021
4 FORM 4 - 0001179110-21-006906 Jun 21, 2021 Jun 17, 2021
8-K FORM 8-K 0001104659-21-082585 Jun 17, 2021
S-8 FORM S-8 0001104659-21-081982 Jun 16, 2021
8-K FORM 8-K 0001171843-21-003256 May 6, 2021
10-Q FORM 10-Q 0001104659-21-062387 May 6, 2021 Mar 31, 2021
DEF 14A DEF 14A 0001104659-21-055589 Apr 27, 2021 Jun 17, 2021
8-K FORM 8-K 0001171843-21-002135 Mar 29, 2021
10-K 10-K 0001104659-21-043161 Mar 29, 2021 Dec 31, 2020
SC 13G COWEN FINANCIAL PRODUCTS LLC 0001085146-21-001052 Feb 25, 2021
SC 13G SC 13G 0001104659-21-023928 Feb 16, 2021
SC 13G/A 0001493152-21-003530 Feb 12, 2021
SC 13G/A SC 13G/A 0001193125-21-041686 Feb 12, 2021
SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-21-000324 Feb 11, 2021
SC 13G/A CELLDEX THERAPEUTICS, INC. 0000902664-21-001119 Feb 11, 2021
SC 13G/A 0001037389-21-000083 Feb 10, 2021
8-K FORM 8-K 0001104659-21-000104 Jan 4, 2021 Jan 1, 2021
3 OWNERSHIP DOCUMENT 0001104659-21-000105 Jan 4, 2021 Jan 1, 2021
4 FORM 4 - 0001179110-20-011996 Dec 16, 2020 Dec 14, 2020
S-3ASR S-3ASR 0001104659-20-122483 Nov 6, 2020
8-K FORM 8-K 0001104659-20-122521 Nov 6, 2020
10-Q FORM 10-Q 0001104659-20-121786 Nov 5, 2020 Sep 30, 2020
8-K FORM 8-K 0001171843-20-007664 Nov 5, 2020
SC 13G 0000935836-20-000571 Oct 22, 2020
8-K FORM 8-K 0001104659-20-096505 Aug 18, 2020
8-K FORM 8-K 0001171843-20-005651 Aug 6, 2020
10-Q FORM 10-Q 0001104659-20-091459 Aug 6, 2020 Jun 30, 2020
SC 13G CELLDEX THERAPEUTICS, INC. 0000902664-20-002780 Jul 24, 2020
S-8 S-8 0001104659-20-077437 Jun 26, 2020
SC 13G THE SCHEDULE 13G 0000921895-20-001867 Jun 26, 2020
4 FORM 4 - 0001179110-20-007593 Jun 19, 2020 Jun 18, 2020
4 FORM 4 - 0001179110-20-007594 Jun 19, 2020 Jun 18, 2020
4 FORM 4 - 0001179110-20-007595 Jun 19, 2020 Jun 18, 2020
4 FORM 4 - 0001179110-20-007596 Jun 19, 2020 Jun 18, 2020
4 FORM 4 - 0001179110-20-007597 Jun 19, 2020 Jun 18, 2020